Additionally, both CD4+ CD62L+ and CD8+ CD62L+ T cells were increased in severe COVID-19 patients with diabetes in our cohort, and CD4+ CD62L+ T cells were increased in severely ill COVID-19 patients with hypertension. This evidence concerns the gene CD4 and COVID-19.